NCT04734444View on ClinicalTrials.gov

SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Brain TumourHigh Grade GliomaLow-grade GliomaGlioblastoma
Interventions
DEVICE

SonoClear ACF

The SonoClear ACF is intended to be used as an acoustic coupling fluid during ultrasound imaging in brain surgery of human beings

Trial Locations (4)

20133

"Instituto Neurologico C. Besta", Milan

35037

Philipps-Universität Marburg, Marburg

83305

University Hospital Bratislava, Bratislava

89312

Universitätsklinikum Ulm, Günzburg

All Listed Sponsors
lead

SonoClear AS

INDUSTRY

NCT04734444 - SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue | Biotech Hunter | Biotech Hunter